High-level ceftazidime/avibactam resistance in Escherichia coli conferred by the novel plasmid-mediated β-lactamase CMY-185 variant is a research paper published in Journal of Antimicrobial Chemotherapy (2023). On theSindex it has a DataRank of 0. It has been cited 21 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Allergy and Infectious Diseases
Grant: R01AI104895
National Institute of Allergy and Infectious Diseases
Grant: R21AI135522
NIAID NIH HHS
Grant: R21 AI151363
NIAID NIH HHS
Grant: R21 AI175821
NIAID NIH HHS
Grant: T32 AI141349
NIAID NIH HHS
Grant: R21 AI151362
NIAID NIH HHS
Grant: P01 AI152999
NIAID NIH HHS
Grant: R21 AI151536
NIH HHS
Grant: S10 OD024977
University of Texas MD Anderson Cancer Center
Takeda Science Foundation
FWCI
1.77
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords